ClinicalTrials.Veeva

Menu

Comparative Effectiveness in the Management of Irreversible Pulpitis

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Begins enrollment in 9 months

Conditions

Irreversible Pulpitis

Treatments

Procedure: RCT
Procedure: Pulpotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT04922229
IRB-300001234

Details and patient eligibility

About

This project addresses a central question within the practice of dentistry: Is a pulpotomy procedure effective in the treatment of a tooth with symptomatic irreversible pulpitis and normal periapex? In addition, the project seeks to identify clinical and molecular biomarkers that are predictive of the success of pulpotomy.

Full description

In this study, patients will be randomized to two groups. All patients will have a diagnosis of irreversible pulpitis with normal apical tissues. The groups will be root canal treatment and pulpotomy. The patients will be followed clinically and radiographically for 2 years following the treatment. Predictors of the outcome of pulpotomy will be clinical and laboratory-based parameters.

Enrollment

138 estimated patients

Sex

All

Ages

12 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Maxillary or mandibular first or second mature permanent molars with carious lesions or restorations (excluding crowns), with signs and symptoms of symptomatic irreversible pulpitis (defined as spontaneous pulpal pain and cold hyperalgesia >30 seconds), and normal apical tissues.
  • Tooth is responsive to cold and electrical pulp testing.
  • Patients aged ≥12 years for first molars and ≥16 years for second molars.

Exclusion criteria

  • Evidence of Pulp Necrosis or Apical Periodontitis, preoperatively or upon inspection of an exposure site
  • Teeth that are badly broken down and/or are not restorable.
  • Teeth with mechanical allodynia assessed by registering bite force that is at least 50N lower than the contralateral side.
  • Teeth with radiographic evidence of internal, or external cervical, inflammatory or replacement root resorption, or with complete pulp canal obliteration.
  • Radiographic evidence of PDL space wider than three times normal width
  • Clinical evidence of swelling or sinus tract
  • Periodontal pocket probing depth ≥5 mm in any site around the tooth.
  • Clinical evidence of cracks connecting mesial and distal surfaces and/or extending in pulp chamber or associated with periodontal pockets ≥ 5 mm.
  • History of taking centrally acting drugs (e.g., tricyclic antidepressants), which interfere with the release of pain mediators and/or modify pain experience, within the previous 6 months.
  • Use of medications that affect the host response such as methotrexate, corticosteroids or cyclosporin.
  • Patients on immunosuppressive agents, chronic corticosteroid use, autoimmune disease, or other immunocompromising diseases or medications.
  • Patients who require IV sedation or general anesthesia for their dental treatment.
  • Teeth with full coverage crowns.
  • Teeth undergoing active orthodontic movement.
  • Teeth that require elective RCTx to place a post for restorative purposes.
  • Teeth with no contralateral molars with normal pulp and periapical tissues for bite and pulp testing controls.
  • Teeth in the pulpotomy group in which, following complete pulpotomy, bleeding does not stop after 10 minutes with 3-4% hypochlorite cotton pellet. These will be considered treatment failure and treated with RCTx.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

138 participants in 2 patient groups

Root canal treatment (RCT)
Active Comparator group
Description:
For cases with this diagnosis RCT is the standard of care and will be done according to clinically approved protocols
Treatment:
Procedure: RCT
Pulpotomy
Experimental group
Description:
Pulpotomy with tricalcium silicates has shown high clinical success in these cases. However, it is not known how this success compares to RCT under similar conditions and with an intent-to-treat study design, which will be employed here.
Treatment:
Procedure: Pulpotomy

Trial contacts and locations

1

Loading...

Central trial contact

Sheila Turner, DDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems